ketoconazole has been researched along with dihydropyridines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, D; Liu, XQ; Qian, ZY; Wang, GJ; Zhao, Y | 1 |
| Liu, ZG; Mei, QB; Yang, TH; Yang, ZF; Zhou, SY | 1 |
| Choi, DH; Choi, JS; Li, C | 1 |
3 other study(ies) available for ketoconazole and dihydropyridines
| Article | Year |
|---|---|
Metabolism and metabolic inhibition of cilnidipine in human liver microsomes.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dihydropyridines; Humans; In Vitro Techniques; Ketoconazole; Microsomes, Liver; Oxidoreductases, N-Demethylating | 2003 |
[Metabolic kinetics of MN9202 in Beagle dog liver microsomes].
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Calcium Channel Blockers; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A Inhibitors; Dihydropyridines; Dogs; Ketoconazole; Microsomes, Liver; Mixed Function Oxygenases; Nitrobenzenes; Tranylcypromine; Troleandomycin | 2005 |
Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipine.
Topics: Animals; Antihypertensive Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biocatalysis; Biological Availability; Blood Glucose; Carbamates; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydropyridines; Drug Interactions; Humans; Hypoglycemic Agents; Ketoconazole; Male; Models, Biological; Nitrophenols; Organophosphorus Compounds; Pharmacological Phenomena; Piperidines; Rats; Rats, Sprague-Dawley; Rhodamine 123 | 2012 |